Arch Chemicals, Inc. Takeover under Investor Investigation

July 11, 2011 - PRLog -- The announcement Arch Chemicals Inc that it agreed to be acquired by Lonza Group Ltd. prompted an investigation on behalf of investors of Arch Chemicals, Inc.  concerning whether the offer to take over Arch Chemicals and the sale process are unfair to investors of Arch Chemicals  and whether certain of its officers and directors or others breached their fiduciary duties owed investors in Arch Chemicals (ARJ) shares.

If you are a current investor in Arch Chemicals, Inc.  and purchased your NYSE-ARJ shares prior to the announcement, and/or if you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether the Arch Chemicals, certain of its officers and directors, and/or others breached their fiduciary duties owed to Arch Chemicals, Inc.  investors in connection with the proposed takeover.

On Monday, July 11, 2011, Arch Chemicals, Inc.  and Lonza Group Ltd (SIX: LONN) announced that they have signed an agreement pursuant to which Lonza Group Ltd has agreed to commence a tender offer for 100 percent of Arch Chemicals’ outstanding shares of common stock at a price of USD 47.20 per share in cash.
Arch Chemicals, Inc said that Lonza Group Ltd’s offer represents a 36.7% premium to Arch Chemicals’ average closing price over the last 30 trading days.

However, shares of Arch Chemicals, Inc.  rose from $42.62 on Friday to $46.90 on Monday, leaving stockholders of ARJ shares with only a meager premium.

The investigation concerns whether the Arch Chemicals Board of Directors undertook an adequate and in particular breached their fiduciary duties to the Arch Chemicals, Inc.  shareholder by failing to adequately shop the Company before entering into the transaction.

The investigation concerns also whether Lonza Group Ltd. would underpay for NYSE- ARJ shares, thus unlawfully harming Arch Chemicals stockholders.

Arch Chemicals’ annual Revenue rose from $1.3billion in 2007 to $1.37billion in 2010. Its Net Income more than doubled within the same time frame. Its Net Income increased from $35.3million in 07 to $70.70million. For the first quarter in 2011 Arch Chemicals, Inc. reported quarterly Revenue of $325.50million compared to $298.70million one year earlier.

A potential securities class action lawsuit would seek to maximize the amount of money and information NYSE-ARJ shareholders would receive in a buyout, so the law firm.

Those who are current investors in Arch Chemicals, Inc. (Public, NYSE- ARJ) and purchased your NYSE ARJ shares prior to the announcement, and/or those who have any information relating the investigation, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

# # #

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group. We do research related to shareholder issues and inform investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. At Shareholders Foundation, Inc. we are in contact with a large number of shareholders. We offer help, support, and assistance for every shareholder. We help investors find answers to their questions and equitable solutions to their problems. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.